The group has worked on initiatives to promote hospital care quality, clinical trials with drugs (I-III), prehabilitation in patients with localized disease and collaboration with other institutions (IMDEA).
It is a multidisciplinary group dedicated mainly to healthcare activities that works in close collaboration with the biobank. Research activities are embedded in the daily clinical activity.
Other groups
We aim to tackle pancreatic cancer dreadful reality by using in vivo and ex vivo models that faithfully recapitulate the genetic alterations commonly found in patients. In the lab, we have successfully developed and established orthotopic and metastatic syngeneic...
The Glycoimmunology Laboratory, led by Dr. Gabriel Rabinovich and currently based at the CaixaResearch Institute (Barcelona), investigates immunoregulatory circuits mediated by lectinin a wide variety of pathological contexts, including cancer, autoimmune diseases,...
Our group at IrsiCaixa focuses on the development of innovative therapeutic strategies against solid tumors, with a particular emphasis on pancreatic cancer. The group integrates immunological, molecular, and translational approaches to design and evaluate cancer...
